News

The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.

The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.

Our September issue review highlights includes:

·        Future directions for peptide therapeutics development
·        Therapeutic potential of neuregulin-1 in cardiovascular diseases
·        The virtue of translational PKPD modeling in drug discovery
·        Parthenolide: from plant shoots to cancer roots
 
 
Cover Story
The leading story of this issue of Drug Discovery Today provides an overview of the pipeline, including therapeutic area and molecular targets, with a focus on glucagon-like peptide 1 receptor agonists. In addition, areas for potential expansion, for example, constrained peptides and peptide–drug conjugates, are profiled. 
Click here to view the Drug Discovery Today September issue on ScienceDirect
To register for the Drug Discovery Today Digital Edition click here.

Share this article

More services

 

This article is featured in:
Novel Technologies

 

Comment on this article

You must be registered and logged in to leave a comment about this article.